These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32322956)

  • 21. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
    McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies.
    Ashfaq UA; Qasim M; Yousaf MZ; Awan MT; Jahan S
    J Transl Med; 2011 Nov; 9():194. PubMed ID: 22074322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Oxo-1-[(2,3,6,7-tetramethoxy-9-phenanthrenyl)methyl]-L-proline Inhibits Hepatitis C Virus Entry.
    Nguyen LP; Park C; Luong TTD; Park EM; Choi DH; Han KM; Mai HN; Nguyen HC; Lim YS; Hwang SB
    Sci Rep; 2019 May; 9(1):7288. PubMed ID: 31086268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tandem overexpression of five human factors renders murine hepatocytes susceptible to hepatitis C virus.
    Lv L; Kang Q; Yu X; Gao B; Hu T; Ma P; Zhang Y; Yan F; Xiao J; Deng J; Zhou X; Xu J
    Acta Virol; 2015 Mar; 59(1):20-6. PubMed ID: 25790047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81.
    Tian ZF; Shen H; Fu XH; Chen YC; Blum HE; Baumert TF; Zhao XP
    World J Gastroenterol; 2009 Jan; 15(2):240-4. PubMed ID: 19132776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of transferrin receptor 1 as a hepatitis C virus entry factor.
    Martin DN; Uprichard SL
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10777-82. PubMed ID: 23754414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry.
    Bertaux C; Dragic T
    J Virol; 2006 May; 80(10):4940-8. PubMed ID: 16641285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
    Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
    J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
    McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P
    J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection.
    Bose M; Mullick R; Das S; Das S; Karande AA
    Virus Res; 2016 Sep; 224():46-57. PubMed ID: 27574733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein.
    Al Olaby RR; Cocquerel L; Zemla A; Saas L; Dubuisson J; Vielmetter J; Marcotrigiano J; Khan AG; Vences Catalan F; Perryman AL; Freundlich JS; Forli S; Levy S; Balhorn R; Azzazy HM
    PLoS One; 2014; 9(10):e111333. PubMed ID: 25357246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential interaction strategies of hepatitis c virus genotypes during entry - An in silico investigation of envelope glycoprotein E2 - CD81 interaction.
    Bhattacharjee C; Nandy SK; Das P; Mukhopadhyay A
    Infect Genet Evol; 2019 Apr; 69():48-60. PubMed ID: 30639544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity.
    Keck ZY; Li SH; Xia J; von Hahn T; Balfe P; McKeating JA; Witteveldt J; Patel AH; Alter H; Rice CM; Foung SK
    J Virol; 2009 Jun; 83(12):6149-60. PubMed ID: 19321602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.
    Witteveldt J; Evans MJ; Bitzegeio J; Koutsoudakis G; Owsianka AM; Angus AG; Keck ZY; Foung SK; Pietschmann T; Rice CM; Patel AH
    J Gen Virol; 2009 Jan; 90(Pt 1):48-58. PubMed ID: 19088272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81.
    Qian XJ; Jin YS; Chen HS; Xu QQ; Ren H; Zhu SY; Tang HL; Wang Y; Zhao P; Qi ZT; Zhu YZ
    J Gen Virol; 2016 May; 97(5):1134-1144. PubMed ID: 26879209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
    Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
    J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.
    Rothwangl KB; Manicassamy B; Uprichard SL; Rong L
    Virol J; 2008 Mar; 5():46. PubMed ID: 18355410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.
    Douam F; Bobay LM; Maurin G; Fresquet J; Calland N; Maisse C; Durand T; Cosset FL; Féray C; Lavillette D
    J Virol; 2016 Jan; 90(2):992-1008. PubMed ID: 26537674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatoma polarization limits CD81 and hepatitis C virus dynamics.
    Harris HJ; Clerte C; Farquhar MJ; Goodall M; Hu K; Rassam P; Dosset P; Wilson GK; Balfe P; Ijzendoorn SC; Milhiet PE; McKeating JA
    Cell Microbiol; 2013 Mar; 15(3):430-45. PubMed ID: 23126643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
    Zhang S; Kodys K; Babcock GJ; Szabo G
    Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.